[HTML][HTML] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC Van Uden… - Pharmacy Practice …, 2020 - SciELO Espana
MOERLIE, Ashwin R et al. Inpatient prescribing of dual antiplatelet therapy according to the
guidelines: a prospective intervention study. Pharmacy Pract (Granada)[online]. 2020, vol …
guidelines: a prospective intervention study. Pharmacy Pract (Granada)[online]. 2020, vol …
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC Van Uden, AK Mantel-Teeuwisse… - sidalc.net
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
[HTML][HTML] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC van Uden, AK Mantel… - Pharmacy …, 2020 - pharmacypractice.org
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
[PDF][PDF] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR MOERLIE, RC VAN UDEN… - pdfs.semanticscholar.org
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
[PDF][PDF] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC Van Uden, AK Mantel-Teeuwisse… - Pharmacy …, 2020 - redalyc.org
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC van Uden, AK Mantel… - Pharmacy Practice …, 2020 - dialnet.unirioja.es
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
[PDF][PDF] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR MOERLIE, RC VAN UDEN… - scienceopen.com
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study.
AR Moerlie, RCV Uden, AK Mantel-Teeuwisse… - Pharmacy …, 2020 - europepmc.org
Background In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
[HTML][HTML] Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC van Uden… - Pharmacy …, 2020 - ncbi.nlm.nih.gov
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
AR Moerlie, RC van Uden, AK Mantel-Teeuwisse… - Pharmacy …, 2020 - research.rug.nl
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …
with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of …